论文部分内容阅读
目的观察低分子肝素联合曲美他嗪治疗高海拔地区不稳定型心绞痛的临床疗效。方法 106例患者随机分为治疗组56例和对照组50例,对照组给予常规治疗,治疗组在对照组基础上给予低分子肝素联合曲美他嗪治疗,观察两组临床疗效、心电图变化与心绞痛发作情况。结果治疗组总有效率为92.85%,对照组总有效率为68.00%,两组比较差异有统计学意义(P<0.05)。结论低分子肝素联合曲美他嗪治疗不稳定型心绞痛疗效显著,值得临床推广应用。
Objective To observe the clinical efficacy of low molecular weight heparin combined with trimetazidine in the treatment of unstable angina at high altitude. Methods 106 patients were randomly divided into treatment group (56 cases) and control group (50 cases). The control group was given routine treatment. The treatment group was given low molecular weight heparin combined with trimetazidine treatment on the basis of control group. The clinical curative effect, electrocardiogram changes Angina pectoris. Results The total effective rate was 92.85% in the treatment group and 68.00% in the control group, with significant difference between the two groups (P <0.05). Conclusion Low molecular weight heparin combined with trimetazidine treatment of unstable angina pectoris has a significant effect, which is worthy of clinical application.